Unilateral Axillary Lymphadenopathy after the Inactivated SARS-COV-2 (CoronaVac) Vaccine: Ultrasonographic Imaging

Unilateral Axillary Lymphadenopathy after the Inactivated SARS-COV-2 (CoronaVac) Vaccine: Ultrasonographic Imaging

Background: Currently, unilateral clinical and subclinical axillary adenopathy cases associated with the Pfizer-BioNTech and Moderna vaccines are increasingly reported. However, only one study on axillary adenopathy due to the CoronaVac vaccine is published. Aims: To present the incidence, severity...

Full description

Bibliographic Details
Main Authors:	Eda Elverici, Arzu Özsoy, Bige Sayın, Muhammet Batuhan Gökhan, Erdem Özkan
Format:	Article
Language:	English
Published:	Galenos Publishing House 2023-01-01
Series:	Balkan Medical Journal
Online Access:	http://www.balkanmedicaljournal.org/text.php?lang=en&id=2454

Similar Items

Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial
by: Samar Samoud, et al.
Published: (2023-08-01)

Humoral Immune Response to CoronaVac in Turkish Adults
by: Yasemin Cosgun, et al.
Published: (2023-01-01)

ANCA-associated vasculitis following the CoronaVac vaccination
by: Yaohui Ma, et al.
Published: (2022-11-01)

An Integrative Analysis of the Immune Features of Inactivated SARS-CoV-2 Vaccine (CoronaVac)
by: Zhujun Jiang, et al.
Published: (2022-05-01)

Effectiveness of CoronaVac in preventing COVID-19 in healthcare workers
by: Gulsum Iclal Bayhan, et al.
Published: (2022-01-01)

Adverse events associated with CoronaVac in a university hospital
by: Lana N. SILVA-SANTOS, et al.
Published: (2022-12-01)

Antibody dynamics post-Comirnaty and CoronaVac vaccination in Malaysia
by: Cheng Siang Tan, et al.
Published: (2022-09-01)

CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2
by: Lairun Jin, et al.
Published: (2022-11-01)

Comparative Safety and Effectiveness of Heterologous CoronaVac–ChAdOx1 versus Homologous CoronaVac Vaccination in a Real-World Setting: A Retrospective Cohort Study
by: Ayakarn Ruenkham, et al.
Published: (2023-09-01)

BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses among Transplant Recipients Who Had Received Two Doses of CoronaVac
by: Çiğdem Erol, et al.
Published: (2023-07-01)

Safety and Adverse Effects of Inactive SARS-Cov-2 Vaccine (CoronaVac) in Health Care Professionals
by: Eda Celik Guzel, et al.
Published: (2022-08-01)

A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: Case report
by: Nahide Onsun, et al.
Published: (2021-05-01)

Coronavirus Disease 2019 Frequency After CoronaVac Vaccine: Ascovid Study
by: Burcu Öztürk Şahin, et al.
Published: (2023-01-01)

The Early-Term Adverse Effects in Healthcare Personnel after CoronaVac Vaccination
by: Mehmet Kabak, et al.
Published: (2022-03-01)

Longitudinal evaluation of innate immune responses to three doses of CoronaVac vaccine
by: Cheng Cao, et al.
Published: (2023-10-01)

Immune Thrombocytopenic Purpura following CoronaVac vaccination: a case report
by: Giulia Eduarda Turra Aimi, et al.
Published: (2023-03-01)

Prevalence and Risk Factors of CoronaVac Side Effects: An Independent Cross-Sectional Study among Healthcare Workers in Turkey
by: Abanoub Riad, et al.
Published: (2021-06-01)

Effectiveness of the BNT162b2 and the CoronaVac vaccines and boosters in healthcare workers
by: Hazal Cansu Çulpan, et al.
Published: (2023-12-01)

Longitudinal analysis of memory Tfh cells and antibody response following CoronaVac vaccination
by: Pengcheng Zhou, et al.
Published: (2023-08-01)

Body Mass Index, Age, and Gender Affect CoronaVac Vaccine Antibody Response
by: Ayfer ÇOLAK, et al.
Published: (2022-08-01)

Efficacy of BNT162b2 and CoronaVac in patients diagnosed with COVID-19
by: Dogan Mustafa, et al.
Published: (2023-06-01)

Safety and immunogenicity following a homologous booster dose of CoronaVac in children and adolescents
by: Lei Wang, et al.
Published: (2022-11-01)

Sobre a eficácia da CoronaVac no Twitter: conversações e aspectos políticos
by: Carina Luisa Ochi Flexor, et al.
Published: (2022-12-01)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
by: Yun Shan Goh, et al.
Published: (2022-01-01)

Humoral and cellular immune responses to CoronaVac up to one year after vaccination
by: Priscilla Ramos Costa, et al.
Published: (2022-10-01)

Effectiveness of the CoronaVac® vaccine in a region of the Colombian Amazon, was herd immunity achieved?
by: Héctor Serrano-Coll, et al.
Published: (2022-01-01)

CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes
by: Laisuan W, et al.
Published: (2021-10-01)

Immunogenicity and immune-persistence of the CoronaVac or Covilo inactivated COVID-19 Vaccine: a 6-month population-based cohort study
by: Qianhui Hua, et al.
Published: (2022-08-01)

The 6-Month Antibody Durability of Heterologous Convidecia Plus CoronaVac and Homologous CoronaVac Immunizations in People Aged 18–59 Years and over 60 Years Based on Two Randomized Controlled Trials in China
by: Hudachuan Jiang, et al.
Published: (2023-12-01)

Comparison of immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccine (CoronaVac) in previously SARS-CoV-2 infected and uninfected health care workers
by: Ahmet Soysal, et al.
Published: (2021-11-01)

Association Between the Effectiveness and Immunogenicity of Inactivated SARS-CoV2 Vaccine (CoronaVac) with the Presence of Hypertension among Health Care Workers
by: Achmad Rifai, et al.
Published: (2022-04-01)

The Predictive Value of Gut Microbiota Composition for Sustained Immunogenicity following Two Doses of CoronaVac
by: Ho-Yu Ng, et al.
Published: (2024-02-01)

A real-world study on the effectiveness of BBIBP-CorV and CoronaVac in Nanjing area
by: Min Huang, et al.
Published: (2023-12-01)

Retinal artery occlusion following CoronaVac injection in a 45-year-old Filipino
by: Mendoza, Daniel Jose M., et al.
Published: (2023-07-01)

Risk of adverse events following CoronaVac's COVID-19 vaccination in women with and without autoimmunity
by: Stevent Sumantri, et al.
Published: (2023-03-01)

Olfactory Dysfunction Following CoronaVac Coronavirus Disease 2019 Vaccination: A Case Report
by: Ayhan Kars, et al.
Published: (2023-04-01)

Anti-nucleocapsid Antibody Response After Two Doses of CoronaVac® Among Healthcare Workers
by: Ayşin KILINÇ TOKER, et al.
Published: (2022-05-01)

Relative Vaccine Effectiveness of the Third Dose of CoronaVac or BNT162b2 Following a Two-Dose CoronaVac Regimen: A Prospective Observational Cohort Study from an Adult Vaccine Center in Turkey
by: Meliha Cagla Sonmezer, et al.
Published: (2022-07-01)

Cord blood antibody following maternal SARS-CoV-2 inactive vaccine (CoronaVac) administration during the pregnancy
by: Ahmet Soysal, et al.
Published: (2021-10-01)

Immune Response to CoronaVac and Its Safety in Patients with Type 2 Diabetes Compared with Healthcare Workers
by: Bothamai Dechates, et al.
Published: (2023-03-01)